https://www.selleckchem.com/pr....oducts/LY2228820.htm
Secondary stent patency rate was 86.7% at a mean follow-up of 22.3 ± 14.2 months (range, 6-48), as assessed by Duplex ultrasound. Single-session of PMT using the Aspirex®S device is a safe and effective therapeutic option in patients presenting with acute symptomatic iliofemoral DVT.(1) Background myeloproliferative neoplasms (MPNs) are slowly developing hematological cancers characterized by few driver mutations, with JAK2V617F being the most prevalent. (2) Methods using mechanism-based mathematical modeling (MM) of hematopoietic ste
Beğen
Yorum Yap
Paylaş
